| 产品描述: | Emlenoflast (MCC7840), a sulfonylurea, is a potent and selective inhibitor of NLRP3 inflammasome, with an IC50 of <100 nM. Emlenoflast can be used for the research of inflammatory diseases |
| 靶点: |
NLRP3 inflammasome:<100 nM (IC50) |
| 体外研究: |
Emlenoflast, a MCC950 analogue, shows useful activity in the inhibition of activation of the NLRP3 inflammasome, with an IC50 of <100 nM. |
| 体内研究: |
Emlenoflast (4 mg/kg; i.v.) exhibits the half-life (3.39 h), AUC0-last (107097 ng•h/mL) and CL (0.621 mL/min/kg) in mice. Emlenoflast (20 mg/kg; p.o.) exhibits the oral bioavailability (67.2%), Cmax (60467 ng/mL) and half-life (5.02 h) in mice.Animal Model: Male C57BL/6 mice (7-9 weeks)Dosage: 4 mg/kg for i.v. and 20 mg/kg for p.o. (Pharmacokinetic Analysis)Administration: A single intravenousbolus or oral gavageResult: I.v.: t1/2=3.39 h; AUC0-last=107097 ng•h/mL; CL=0.621 mL/min/kg.P.o.: F=67.2%; Cmax=60467 ng/mL; t1/2=5.02 h. |
| 参考文献: |
1. El-Sharkawy LY, et, al. Inhibiting the NLRP3 Inflammasome. Molecules. 2020 Nov 25;25(23):5533.
2. O'neill L, et, al. Sulfonylureas and related compounds and use of same. WO2016131098A1. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.574 ml |
12.871 ml |
25.741 ml |
| 5 mM |
0.515 ml |
2.574 ml |
5.148 ml |
| 10 mM |
0.257 ml |
1.287 ml |
2.574 ml |
| 50 mM |
0.051 ml |
0.257 ml |
0.515 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |